Background and Purpose-Besides the established spot sign (SS) in computed tomography angiography (CTA), there is growing evidence that different imaging markers in noncontrast CT offer great value for outcome prediction in patients with intracerebral hemorrhage (ICH). However, it is unclear how the concurrent presence of each sign independently contributes to the predictive power of poor outcome. We, therefore, aimed to clarify the predictive value of 5 recently published noncontrast CT parameters (blend sign, black hole sign, island sign, hematoma heterogeneity, and hypodensities) and the established SS in 1 consecutive series of patients with ICH. Methods-Retrospective study of patients with ICH at 2 German tertiary stroke centers; inclusion criteria were (1) spontaneous ICH and (2) 
arly hematoma growth occurs in ≈one-third of the patients with spontaneous intracerebral hemorrhage (ICH). 1 In line with initial hematoma volume and hematoma location, hematoma growth presents an independent predictor of poor functional outcome, [2] [3] [4] [5] but in contrast to them it is potentially modifiable if detected early enough and, therefore, presents an appealing therapeutic target. 6, 7 Different imaging characteristics for prediction of hematoma growth in noncontrast computed tomography (NCCT) have been introduced recently, including the blend sign (BS), black hole sign (BHS), island sign (IS), and the more general appearance of hypodensities. [8] [9] [10] The major advantage of the NCCT imaging markers is the greater availability in clinical routine. Additionally, allergic reactions to contrast medium and renal dysfunction present possible contraindications for contrast application.
Our group has found an association between the appearance of the BS and a secondary neurological deterioration
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and showed that BS and BHS predict poor neurological outcome. However, the impact of the IS on neurological outcome is unclear. Moreover, this multicentre series compares the unclear interaction of BS, BHS, IS, and hypodensities in NCCT and the established spot sign (SS) in CTA and their individual contribution for prediction of neurological outcome in 1 study. Some published signs, such as the BHS (briefly a hypodense BH visible in the hemorrhage) and hypodensities may overlap to some extent, even though the appearance of hypodensities is reported to be much more frequent but less specific.
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Methods
Because of subject confidentiality, the imaging data are not available to researchers. Summary data and analytical methods are available from the corresponding author on reasonable request.
Study Design
We retrospectively studied the databases of 2 German tertiary stroke centers (University Hospital of Muenster and University Hospital Hamburg-Eppendorf) for patients with ICH aged >18 years between January 2013 and December 2017.
As inclusion criteria we defined (1) primary spontaneous ICH confirmed on NCCT and (2) NCCT and CTA performed on admission within 6 hours after onset of symptoms. Patients were excluded if they had head trauma, brain tumor, vascular malformation, anticoagulant treatment, primary intraventricular hemorrhage, or secondary ICH from hemorrhagic transformation of ischemic infarction.
We defined a binary outcome (good versus poor): as poor outcome we defined modified Rankin Scale on discharge >3, good outcome was defined as modified Rankin Scale score of ≤3. Additionally, we obtained vascular risk factors (hypertension and diabetes mellitus) from patients' clinical records.
The study was approved by the responsible ethics committee. All study protocols and procedures were conducted in accordance with the Declaration of Helsinki. Patient consent was not needed (because of the nature of the study).
Imaging Analysis
The CT scans were performed using standard clinical parameters with axial 5 mm section thickness. The images were obtained and stored for further evaluation. The location of the hematoma was assessed and documented. The hemorrhage locations were classified as deep, lobar, brain stem, and cerebellum. Two experienced readers independently evaluated the presence of NCCT imaging markers in all patients' NCCT's and then independently evaluated the presence of SS in the corresponding CTA's. Both readers were blinded to all clinical information and the other scans at the time of the ratings. Discrepancies about the occurrence of the signs were settled by joint discussion of the 2 readers. All signs were defined as recently published. 8, [10] [11] [12] [13] Briefly, the BHS consists of a relatively hypodense area (BH) which is encapsulated within a hyperdense area and which is not connected with the adjacent brain tissue. The relatively hypodense area has an identifiable border and a difference of at least 28 Hounsfield Units between the 2 density regions. 10 The hematoma BS 6 represents a hematoma with a hyperdense and a hypodense area, which show a well-defined margin that is easily recognized by the naked eye. There should be a difference of at least 18 Hounsfield Units between the 2 regions, and the hypodense area should not be encapsulated by the hyperdense part of the hematoma. The hematoma IS consists of at least 3 scattered small hematomas all separate from the main hematoma or at least 4 small hematomas some or all of which may connect with the main hematoma. 13 The imaging sign hypodensities were defined as recently published 11, 12 (for example, Figure 1) .
Moreover, all NCCTs were rated with respect to density as defined by Barras et al. 14 After their definition, we divided the category density into homogeneous and heterogeneous. 14 The ICH volumes of the baseline CT were segmented using Analyze (Analyze 10.0, AnalyzeDirect Inc, Overland Park). We, therefore, extracted the DICOM data of CT scans and implemented them into Analyze. Here the hematoma volume was segmented slice by slice.
Statistical Analysis
Univariable distribution of metric variables is described by median and interquartile range. Absolute and relative frequencies are given for categorical data. Mann-Whitney U test or χ 2 test was used to compare 2 independent samples on a metric or categorical outcome, respectively.
Sensitivity, specificity, positive predictive value, and negative predictive value of BHS, BS, hypodensities, IS, and SS are given with exact 95% CI. The underlying gold standard is outcome (good or poor) as defined above in the patients section. Discrepancies about the occurrence of the imaging signs were settled by joined discussion. To measure interrater agreement we used Cohen's kappa.
Association between clinical and radiological parameters and outcome (good or poor) was assessed by logistic regression analysis. For multivariable model building, stepwise forward selection was used (inclusion criterion, P value of the score test ≤0.05 and exclusion criterion, P value of the likelihood ratio test >0.1). Then, the factors of the model from step 1 were fitted together with all pairwise interactions in a second block using stepwise forward selection (inclusion, P value of the score test ≤0.05 and exclusion, P value of the likelihood ratio test >0.1). Regression coefficients were calculated in R (v3.02) using iterative maximum likelihood estimation method and tested for robustness with leave-one-out cross validation for unbiased estimate of the prediction error. 15, 16 Thus, infarct prediction was validated in each single patient by leave-one-out cross validation using the coefficients obtained from the remaining patients as training set (Figure in the online-only Data Supplement).
Variables considered for multivariable model building are given in Table 1 . Given for selected variables are odds ratios (ORs) with 95% CI and P value of likelihood ratio test. For nonselected variables, P value of score test is displayed. Odds were calculated as ratio of the probability for secondary for poor outcome to the probability for good outcome.
No adjustment for multiple testing was performed, and analyses are regarded as explorative. Local, unadjusted P values ≤0.05 were considered as statistically noticeable.
Statistical analyses were performed in SPSS version 24 (IBM Corporation, Armonk, NY).
Results
Baseline Characteristics
A total of 201 patients fulfilled the inclusion criteria, no patients had to be excluded from the analysis. The median age of the patients was 68 years (interquartile range, 55-79). Ninety-one (45.3%) were female, and 110 (54.7%) were male. Poor outcome was observed in 114 patients (56.7%) with ICH. The median hematoma volume was 23.0 mL (interquartile range, 8.5-42.7) and differed noticeably between patients with poor (median, 31.5 mL) and good outcome (median, 11.8 mL; P<0.001). ICH was mostly located deep (n=93, 46.3%), followed by cerebral lobes (n=91, 45.3%), brain stem (n=67, 3.5%), and cerebellum (n=10, 5.9%). Moreover, we obtained risk factors, such as hypertension and diabetes mellitus. Analyses revealed statistically noticeable differences in the distribution of intraventricular hemorrhage (P=0.002), hematoma volume (P<0.001), and the imaging parameters SS, BS, BHS, IS, hypodensities, and heterogeneous densities (all P<0.001) between patients with poor and good outcome (Table 1) . Univariable analysis of predictors of poor outcome using logistic regression. Given are OR with 95% CI and P value of likelihood ratio test if not otherwise specified. ICH indicates intracerebral hemorrhage; and OR, odds ratio.
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Poor Outcome and Interobserver Agreement
Of 201 patients with spontaneous ICH, 28 (13.9%) presented with BHS, 38 (18.9%) with BS, 120 (59.7%) with hypodensities, 97 (48.3%) with heterogeneous densities, IS (26.4%), and 45 (22.4%) with SS ad admission. Nine (4.48%) patients showed all NCCT signs and the CTA SS. All of them had a poor outcome. In contrast, only 19 (28.4 %) out of 67 patients without the presence of SS or BHS/BS/hypodensities/IS/heterogeneous densities showed a poor outcome (Table 1) .
Interrater agreement for identifying BHS, BS, hypodensities, heterogeneous densities, IS, and SS was high between the 2 readers (BHS: κ=0.939, BS: κ=0.967, hypodensities: κ=0.949, heterogeneous densities κ=0.909, IS: κ=0.909, and SS: κ=0.986). Discrepancies between the 2 readers were observed in 1 patient for SS, 3 for BHS, 5 for hypodensities, 4 for heterogeneous densities 7 for IS, and 2 for BS.
Sensitivities, specificities, and positive and negative predictive values are shown in Table in the online-only Data Supplement. Hypodensities had the highest sensitivity (75%) for poor outcome when compared with the other markers; in contrast, the presence of the SS was the most specific (96.6%). However, the SS had the highest positive and hypodensities the highest negative predictive value for poor outcome. BHS and BS showed a higher sensitivity for predicting outcome in the deep versus lobar hemorrhage location (BHS: 77.3% versus 21.6% and BS: 78.9% versus 41.2%) and a higher specificity for predicting outcome in the lobar versus deep hemorrhage location (BHS: 97.5% versus 2.8% and BS: 92.5% versus 2.8%; Table in the online-only Data Supplement).
Logistic regression analysis was performed to assess the association between various clinical and radiological parameters and poor outcome. In univariable logistic regression, higher baseline hematoma volume (P<0.001), intraventricular hemorrhage (P=0.002), and the presence of BHS/BS/hypodensities/IS/SS/heterogeneous density (all P<0.001) on admission CT scan were associated with poor outcome (Table 2) . Multivariable logistic regression analysis confirmed intraventricular hemorrhage (OR, 2.20; P=0.025), higher baseline hematoma volume (OR, 1.02 per mL; P<0.019), and the presence of hypodensities (OR, 2.47; P=0.018) and SS on baseline CT (OR, 12.22; P<0.001) scan as independent predictors of poor outcome (Table 3) . Additional presence of BHS and BS and IS and heterogeneous densities on baseline CT did not further contribute to risk of poor outcome (P=0.627 and P=0.190 and P=0.496 and P=0.761). This may be attributed to the high degree of association between BS and SS (κ=0.651) and between hypodensities and heterogeneous densities (κ=0.753; Figure in the online-only Data Supplement).
According to multivariable analysis, the probability of poor outcome is relevantly affected by the presence of hypodensities and SS (Figure 2) .Although prognosis in patients without SS and hypodensities is poor only in the case of high hematoma volume, additional presence of both signs is an indicator for poor outcome even for small hematoma volumes. For example, for a patient without intraventricular hemorrhage (with intraventricular hemorrhage) and hematoma volume of 20 mL the presence of SS and hypodensities increases the probability of poor outcome from 22% (35%) to 91% (96%); likewise, for a hematoma volume of 60 mL the presence of SS and hypodensities increases the probability of poor outcome from 41% (60%) to 97% (99%; Figures 2 and 3 ).
Discussion
Our results show that all NCCT imaging markers (BS, BHS, IS, hypodensities, and heterogeneous densities) show a strong correlation with the established SS and are promising imaging parameters for prediction of poor neurological outcome.
Prevalence of all signs in our study was comparable to other studies. 8, [10] [11] [12] [13] [17] [18] [19] [20] The highest prevalence had, as expected, the appearance of hypodensities, followed by IS, SS, BS, and BHS. However, the appearance of hypodensities is the least specific imaging marker in NCCT.
Taking into account that SS has a higher sensitivity for outcome prediction than the NCCT imaging markers alone, both NCCT and CTA should be acquired if possible. Especially in a setting where CTA is not readily available or with strong contraindications for contrast application (distinct allergy and far progressed renal dysfunction) sole acquisition of NCCT, and evaluation of NCCT imaging markers is a valuable option for detecting hematoma growth associated with poor outcome.
The high interrater reliability suggests that all included signs are easy to use new imaging parameters. Good Figure 3 . Two patients with good (A+B) and poor outcome (C+D) with similar hematoma volumes of 37 mL. Patient 1 without the presence of hypodensities (A) and without spot sign (B), whereas patient 2 demonstrates a clear hypodensity within the hematoma (C) and a spot sign in the corresponding computed tomography angiography. Note that patient 1 has no intraventricular hemorrhage, whereas patient 2 shows severe intraventricular hemorrhage with ventricular enlargement.
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A strong overlap in our study was observed for BHS and hypodensities, most likely because they both rely on the visibility of a hypodense area within the hematoma. Prediction of poor outcome was best when including all signs leading to the conclusion that whenever possible, all imaging parameters should be evaluated for an optimal assessment.
Moreover, probability of poor outcome is relevantly affected by the presence of SS and hypodensities. For example, for a hematoma volume of 20 mL without intraventricular hemorrhage (with intraventricular hemorrhage) the presence of hypodensities and SS increase the probability of poor outcome from 22% (35%) to 91% (96%).
Limitations of our study are because of its retrospective nature and relatively small sample size. Another limitation is the missing long-term follow-up that might offer additional information but was not available for this study.
Conclusions
This study demonstrates the degree of interaction between 5 recent NCCT imaging markers and SS and their individual contribution for outcome prediction in patients with ICH. Presence of hypodensities was the most frequent and the least specific marker, whereas SS showed the highest specificity for poor outcome. By multivariate analysis, presence of SS and hypodensities independently contributed to poor outcome for any given hematoma volume.
All included NCCT parameters (BS, BHS, IS, hypodensities, and hematoma heterogeneity) are reliable predictors of poor outcome in patients with ICH.
Of the CT imaging signs indicating early hematoma expansion, SS, and hypodensities are the 2 most important independently modulating risk factors for poor outcome after ICH. According to our results, the risk of poor outcome can be significantly elevated even for smaller bleeding volumes.
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